• Candel Therapeutics granted inducement stock options covering 85,900 common shares to four new employees on Sept. 30, 2026.
• Options carry an exercise price of USD 10.44 per share.
• Vesting schedules 25% on the first anniversary of each employee’s start date; remaining 75% vests monthly over 36 months.
• Awards were issued under the company’s 2025 Inducement Plan, adopted on Dec. 24, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011605PRIMZONEFULLFEED9838006) on October 01, 2026, and is solely responsible for the information contained therein.